For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft ...

Bausch Health Cos. fell after the company said its treatment for a liver condition fell short of its goals in two late-stage trials.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.

New fleet of weight loss drugs are more effective than the current popular obesity medications at trial - One in eight ...

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...

The future of cancer drug research just might be in Omaha, Nebraska, between a Panda Express and a Mattress Firm. A big draw is speed: Nordquist says he can open a trial in as little as two weeks, ...

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

FILE - A doctor uses a hand-held Doppler probe on a pregnant woman to measure the heartbeat of the fetus, Dec. 17, 2021, in Jackson, Miss. (AP Photo/Rogelio V. Solis, File) From Philly and the Pa.

In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...